SK111197A3 - Clavulanic acid salts - Google Patents

Clavulanic acid salts Download PDF

Info

Publication number
SK111197A3
SK111197A3 SK1111-97A SK111197A SK111197A3 SK 111197 A3 SK111197 A3 SK 111197A3 SK 111197 A SK111197 A SK 111197A SK 111197 A3 SK111197 A3 SK 111197A3
Authority
SK
Slovakia
Prior art keywords
salt
clavulanic acid
benzhydrylamine
solution
pharmaceutically acceptable
Prior art date
Application number
SK1111-97A
Other languages
English (en)
Slovak (sk)
Inventor
George L Callewaert
Original Assignee
Spurcourt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK111197(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9503839.4A external-priority patent/GB9503839D0/en
Application filed by Spurcourt Ltd filed Critical Spurcourt Ltd
Publication of SK111197A3 publication Critical patent/SK111197A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/10Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK1111-97A 1995-02-25 1996-02-21 Clavulanic acid salts SK111197A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9503839.4A GB9503839D0 (en) 1995-02-25 1995-02-25 Claulanic acid salt
GBGB9520915.1A GB9520915D0 (en) 1995-02-25 1995-10-12 Clavulanic acid salt
PCT/GB1996/000382 WO1996026944A1 (en) 1995-02-25 1996-02-21 Clavulanic acid salts

Publications (1)

Publication Number Publication Date
SK111197A3 true SK111197A3 (en) 1998-01-14

Family

ID=26306586

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1111-97A SK111197A3 (en) 1995-02-25 1996-02-21 Clavulanic acid salts

Country Status (27)

Country Link
US (1) US5726170A (de)
EP (1) EP0729961B1 (de)
JP (1) JPH11501023A (de)
CN (1) CN1175952A (de)
AP (2) AP9701116A0 (de)
AT (1) ATE211143T1 (de)
AU (1) AU691727B2 (de)
BG (1) BG62490B1 (de)
BR (1) BR9607258A (de)
CA (1) CA2213563A1 (de)
CZ (1) CZ266697A3 (de)
DE (1) DE69618045D1 (de)
EE (1) EE9700186A (de)
FI (1) FI973287A (de)
HK (1) HK1006571A1 (de)
IL (1) IL117217A0 (de)
IS (1) IS4541A (de)
MD (1) MD1744F2 (de)
NO (1) NO973744D0 (de)
NZ (1) NZ301765A (de)
OA (1) OA10444A (de)
PL (1) PL321871A1 (de)
SE (1) SE9703056D0 (de)
SK (1) SK111197A3 (de)
TR (1) TR199700828T1 (de)
WO (1) WO1996026944A1 (de)
ZA (1) ZA961457B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9400107A (en) 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
US6414142B1 (en) * 1996-06-13 2002-07-02 Smithkline Beecham Corporation Process for preparing potassium clavulanate
DZ2456A1 (fr) * 1997-04-04 2003-01-18 Smithkline Beecham Plc Procédé de préparation de sels de l'acide clavulanique.
US8034120B2 (en) * 2002-12-20 2011-10-11 Ossur Hf Suspension liner system with seal
CN103304583B (zh) * 2013-07-09 2016-01-20 山东新时代药业有限公司 一种从克拉维酸胺盐结晶母液中回收克拉维酸的方法
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
CN113979856B (zh) * 2021-11-09 2024-04-19 国药集团威奇达药业有限公司 从克拉维酸钾釜残液中回收叔丁胺和异辛酸盐的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB157873A (en) * 1920-01-16 1921-08-17 Schneider & Cie Improvements in gas turbines
GB704438A (en) * 1951-04-06 1954-02-24 Chimiotherapie Lab Franc Penicillin preparations for injection
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
GB1543563A (en) * 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
BE862211A (fr) * 1977-12-22 1978-06-22 Beecham Group Ltd Agents antibacteriens
DE3063683D1 (en) * 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
MX7417E (es) * 1984-10-27 1988-10-14 Antibioticos Sa Metodo para la preparacion de acido clavulanico y sus derivados
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
DK0647229T3 (da) * 1993-03-26 1996-10-07 Gist Brocades Nv Diaminsalte af clavulansyre

Also Published As

Publication number Publication date
ZA961457B (en) 1996-09-26
WO1996026944A1 (en) 1996-09-06
AP9701067A0 (en) 1997-10-31
MD970269A (en) 1999-05-31
AP9701116A0 (en) 1997-10-31
MX9706461A (es) 1998-06-28
AU4726196A (en) 1996-09-18
HK1006571A1 (en) 1999-03-05
CN1175952A (zh) 1998-03-11
ATE211143T1 (de) 2002-01-15
BG101884A (en) 1998-10-30
EE9700186A (et) 1998-02-16
EP0729961B1 (de) 2001-12-19
CZ266697A3 (en) 1997-11-12
NO973744L (no) 1997-08-14
TR199700828T1 (xx) 1998-04-21
AP749A (en) 1999-07-05
CA2213563A1 (en) 1996-09-06
JPH11501023A (ja) 1999-01-26
FI973287A0 (fi) 1997-08-08
BR9607258A (pt) 1997-12-30
IS4541A (is) 1997-08-08
IL117217A0 (en) 1996-06-18
PL321871A1 (en) 1997-12-22
DE69618045D1 (de) 2002-01-31
OA10444A (en) 2002-03-26
FI973287A (fi) 1997-08-22
AU691727B2 (en) 1998-05-21
BG62490B1 (bg) 1999-12-30
SE9703056L (sv) 1997-08-25
SE9703056D0 (sv) 1997-08-25
MD1744F2 (ro) 2001-09-30
NO973744D0 (no) 1997-08-14
NZ301765A (en) 1999-10-28
EP0729961A1 (de) 1996-09-04
US5726170A (en) 1998-03-10

Similar Documents

Publication Publication Date Title
SK111197A3 (en) Clavulanic acid salts
EP0647229B1 (de) Diaminsalze von clavulansäure
CH633556A5 (fr) Amides therapeutiquement actifs et procedes pour les produire.
EP0799233B1 (de) Diclavulanat-salze mit diaminoether und verfahren zu deren herstellung
DE69816057T2 (de) Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte
US5821364A (en) Diamine salts of clavulanic acid
GB2298201A (en) Clavulanic acid benzhydrylamine salts
US5741903A (en) Diamine salts for purification of clavulanic acid
MXPA97006461A (es) Sales de acido clavulanico
CH634326A5 (de) 2-hydroxyiminoacetamido-cephemcarbonsaeuren und ihre herstellung.
KR19980702445A (ko) 클라불란 산 염류
MXPA97004693A (en) Clavulan acid salts
KR100187333B1 (ko) 클라불란산의 디아민염
DE2137386C3 (de) 3-Pyridylthiomethyl -cephalosporinverbindungen, Verfahren zur Herstellung derselben und pharmazeutische Mittel
DE2513954A1 (de) 7-(alpha-furoylureidoaryl- und -cyclohexadienylacetamido)-cephalosporine
DE2941214A1 (de) Ungesaettigte 7-acylamido-3-cephem- 4-carbonsaeurederivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen